Abstract | STUDY OBJECTIVE: DESIGN: Prospective, clinical study. SETTING: University, tertiary referral hospital in the upper Mississippi River valley. PATIENTS: Ninety patients with SPNs. INTERVENTIONS: Independent interpretation of FDG-PET imaging, computed tomography and pathologic evaluation of the SPNs. MEASUREMENTS AND RESULTS: To detect malignant SPNs, FDG-PET imaging had a sensitivity of 93%, a specificity of 40%, a positive predictive value (PPV) of 88% and a negative predictive value (NPV) of 55%. CONCLUSIONS: In a region with a high prevalence of pulmonary fungal infection, FDG-PET is sensitive but has a low specificity and NPV for identifying NSCLC. In our study cohort, FDG-PET does not appear to reduce the need for SPN biopsies.
|
Authors | Donita R Croft, John Trapp, Kemp Kernstine, Peter Kirchner, Brian Mullan, Jeffery Galvin, Michael W Peterson, Thomas Gross, Geoffrey McLennan, Jeffrey A Kern |
Journal | Lung cancer (Amsterdam, Netherlands)
(Lung Cancer)
Vol. 36
Issue 3
Pg. 297-301
(Jun 2002)
ISSN: 0169-5002 [Print] Ireland |
PMID | 12009241
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Radiopharmaceuticals
- Fluorodeoxyglucose F18
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Non-Small-Cell Lung
(diagnostic imaging)
- Diagnosis, Differential
- Female
- Fluorodeoxyglucose F18
- Histoplasmosis
(diagnostic imaging, epidemiology)
- Humans
- Iowa
(epidemiology)
- Lung Neoplasms
(diagnostic imaging)
- Male
- Middle Aged
- Predictive Value of Tests
- Prevalence
- Prospective Studies
- Radiopharmaceuticals
- Sensitivity and Specificity
- Tomography, Emission-Computed
- Tomography, X-Ray Computed
|